An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
GE HealthCare introduces AI-enhanced Voluson Signature 20 and 18 ultrasound systems to advance women's health imaging. The new systems integrate AI, advanced tools, and an ergonomic design to improve image quality, speed up exams, and provide accurate diagnoses. Clinicians can now benefit from features like 'Hey Voluson' voice commands, SonoLyst for fetal anatomy identification, SonoPelvicFloor for pelvic floor assessments, Fibroid Mapping for fibroid documentation, and fetalHS for fetal heart assessments. These advancements aim to enhance patient care and streamline workflows in women's health settings.
GE HealthCare introduce i sistemi ecografici Voluson Signature 20 e 18 potenziati dall'IA per migliorare l'imaging nella salute femminile. I nuovi sistemi integrano intelligenza artificiale, strumenti avanzati e un design ergonomico per migliorare la qualità delle immagini, accelerare gli esami e fornire diagnosi accurate. I clinici possono ora beneficiare di funzionalità come i comandi vocali 'Hey Voluson', SonoLyst per l'identificazione dell'anatomia fetale, SonoPelvicFloor per le valutazioni del pavimento pelvico, la Mappatura dei Fibromi per la documentazione dei fibromi e fetalHS per le valutazioni cardiache fetali. Questi progressi mirano a migliorare l'assistenza al paziente e a ottimizzare i flussi di lavoro nelle strutture sanitarie femminili.
GE HealthCare presenta los sistemas de ultrasonido Voluson Signature 20 y 18 mejorados con IA para avanzar en la imagenología de la salud de la mujer. Los nuevos sistemas integran inteligencia artificial, herramientas avanzadas y un diseño ergonómico para mejorar la calidad de imagen, agilizar los exámenes y proporcionar diagnósticos precisos. Los clínicos ahora pueden beneficiarse de características como comandos de voz 'Hey Voluson', SonoLyst para la identificación de la anatomía fetal, SonoPelvicFloor para evaluaciones del suelo pélvico, Mapeo de Fibroides para la documentación de fibromas y fetalHS para las evaluaciones del corazón fetal. Estos avances buscan mejorar la atención al paciente y agilizar los flujos de trabajo en entornos de salud femenina.
GE 헬스케어는 여성 건강 영상을 향상시키기 위해 AI가 강화된 볼루손 시그니처 20 및 18 초음파 시스템을 도입했습니다. 새로운 시스템은 인공지능, 고급 도구, 인체공학적 디자인을 통합하여 이미지 품질을 향상시키고 검사 속도를 높이며 정확한 진단을 제공합니다. 임상의들은 이제 'Hey Voluson' 음성 명령, 태아 해부학 식별을 위한 SonoLyst, 골반 바닥 평가를 위한 SonoPelvicFloor, 자궁근종 문서화를 위한 Fibroid Mapping, 태아 심장 평가를 위한 fetalHS와 같은 기능을 이용할 수 있습니다. 이러한 발전은 여성 건강 분야에서 환자 치료를 향상시키고 워크플로우를 간소화하는 것을 목표로 합니다.
GE HealthCare introduit les systèmes d'échographie Voluson Signature 20 et 18 améliorés par l'IA pour faire avancer l'imagerie de la santé des femmes. Les nouveaux systèmes intègrent l'intelligence artificielle, des outils avancés et un design ergonomique pour améliorer la qualité des images, accélérer les examens et fournir des diagnostics précis. Les cliniciens peuvent désormais bénéficier de fonctionnalités telles que les commandes vocales 'Hey Voluson', SonoLyst pour l'identification de l'anatomie fœtale, SonoPelvicFloor pour les évaluations du plancher pelvien, la Cartographie des Fibromes pour la documentation des fibromes et fetalHS pour les évaluations cardiaques fœtales. Ces avancées visent à améliorer les soins aux patients et à rationaliser les flux de travail dans les milieux de santé féminine.
GE HealthCare führt die durch KI verbesserten Voluson Signature 20 und 18 Ultraschallsysteme ein, um die Bildgebung in der Frauengesundheit voranzutreiben. Die neuen Systeme integrieren künstliche Intelligenz, fortschrittliche Werkzeuge und ein ergonomisches Design, um die Bildqualität zu verbessern, Untersuchungen zu beschleunigen und genaue Diagnosen zu liefern. Kliniker können nun von Funktionen wie 'Hey Voluson' Sprachbefehlen, SonoLyst zur Identifikation der fetalen Anatomie, SonoPelvicFloor für Beckenbodenbewertungen, Fibroid Mapping für die Dokumentation von Myomen und fetalHS für Herzuntersuchungen des Fötus profitieren. Diese Fortschritte zielen darauf ab, die Patientenversorgung zu verbessern und Arbeitsabläufe im Bereich der Frauengesundheit zu optimieren.
Positive
The introduction of AI-enhanced Voluson Signature 20 and 18 ultrasound systems by GE HealthCare aims to improve women's health imaging.
The systems integrate AI, advanced tools, and an ergonomic design to enhance image quality, speed up exams, and provide accurate diagnoses.
Features like 'Hey Voluson' voice commands, SonoLyst for fetal anatomy identification, SonoPelvicFloor for pelvic floor assessments, Fibroid Mapping for fibroid documentation, and fetalHS for fetal heart assessments aim to streamline workflows and enhance patient care in women's health settings.
The new systems offer time-saving AI-driven applications and advanced automation features to simplify exams and provide clearer images, ultimately leading to better health outcomes for women.
GE HealthCare's Voluson portfolio incorporates a legacy of innovation to deliver exceptional image quality, advanced clinical tools, and intelligent workflow for high-quality, efficient care.
Negative
None.
Integrated artificial intelligence (AI) and advanced tools improve image quality and exam speed to help providers make accurate diagnoses and tailor precision care for women
Latest Voluson Signature ultrasound technology offers an intuitive and ergonomic design allowing clinicians to focus on patient care
CHICAGO--(BUSINESS WIRE)--
GE HealthCare (Nasdaq: GEHC) today announced the launch of the Voluson Signature 20 and 18 ultrasound systems, which comprehensively integrate artificial intelligence (AI), advanced tools and an ergonomic design to speed exam time for clinicians while delivering a clearer picture of various conditions impacting women’s health. These latest systems combine high-performance hardware with flexible scalable software to help increase clinicians’ confidence in their diagnostic and treatment determinations.
Today, patient volumes are increasing and health conditions are becoming more complex – especially for women who face complications related to pregnancy, as well as other conditions impacting the female reproductive system. At the same time, workforce shortages continue to be a major challenge for health systems who are trying to meet these demands, with 42% of clinicians surveyed as part of GE HealthCare’s Reimagining Better Health study considering leaving the healthcare industry. To help address patient demand and reduce staffing burdens, clinicians across the board need tools, including innovative AI-enabled ultrasound technologies, that support a clear, quick and confident diagnosis.
"We've seen huge advancements in ultrasound technology, including the use of AI, resulting in a new era of ultrasound scanning. The new Voluson Signature series features innovative tools clinicians can rely on, and the automated functions help reduce work stress and improve workflows," said Dr. Ben Csapo, Maternal Fetal Medicine Specialist Graz, Austria. "The most important part of our work is building connections with patients and not over-instrumentalizing work. Having a tool that helps clinicians work smarter, faster and easier is a good step forward for patients.”
The latest AI-powered capabilities on the Voluson Signature 20 and 18 enable a number of efficiencies across women’s health care settings.
The new “Hey Voluson” feature allows users to operate the system using voice commands, saving time and keystrokes.
SonoLyst*, a suite of tools that leverage AI to identify fetal anatomy seen on standard views, then automatically annotates and measures where applicable, and can reduce time to complete standard International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) second trimester exams by up to 40%.
SonoPelvicFloor simplifies assessments of the pelvic floor and speeds up exams by automating plane alignment and measurements for an up to 76% keystroke reduction.
Fibroid Mapping uses AI to standardize and streamline fibroid documentation by mapping, measuring, and classifying fibroids.
fetalHS simplifies and speeds fetal heart assessments by up to 48% by providing step-by-step, AI-driven guidance to help identify normal fetal heart anatomy.
In addition, a flexible wireless workflow is now a possibility with the integration of Vscan Air CL wireless dual probe with the new Voluson Signature systems, allowing for a wider range of motion because it is cable free.
“Next-level image clarity can help clinicians detect fetal abnormalities and hard-to-spot gynecological emergencies or conditions like endometriosis earlier, which can make a big difference in a patient’s treatment plan and overall health,” said Gerald Seifriedsberger, general manager, Women’s Health Ultrasound, GE HealthCare. “With proven time-saving AI-driven applications, and advanced automation features that simplify exams, we’re providing technology that can help enhance ease of use and provide clearer images – helping clinicians power through demanding workflows faster while delivering greater consistency and accuracy, ultimately helping deliver better health outcomes for women.”
*SonoLyst incorporates the AI technology of Intelligent Ultrasound.
About GE HealthCare Technologies Inc.
GE HealthCare is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, dedicated to providing integrated solutions, services, and data analytics to make hospitals more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 125 years, GE HealthCare is advancing personalized, connected, and compassionate care, while simplifying the patient’s journey across the care pathway. Together our Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics businesses help improve patient care from diagnosis, to therapy, to monitoring. We are a $19.6 billion business with approximately 51,000 colleagues working to create a world where healthcare has no limits.
What new ultrasound systems has GE HealthCare introduced to advance women's health imaging?
GE HealthCare has introduced the Voluson Signature 20 and 18 ultrasound systems.
What features do the new Voluson Signature 20 and 18 ultrasound systems offer?
The new systems offer features like 'Hey Voluson' voice commands, SonoLyst for fetal anatomy identification, SonoPelvicFloor for pelvic floor assessments, Fibroid Mapping for fibroid documentation, and fetalHS for fetal heart assessments.
How can the 'Hey Voluson' feature benefit users?
The 'Hey Voluson' feature allows users to operate the system using voice commands, saving time and keystrokes.
What is the purpose of the SonoLyst suite of tools?
SonoLyst leverages AI to identify fetal anatomy seen on standard views, automatically annotates and measures where applicable, and can reduce time to complete standard ISUOG second trimester exams by up to 40%.
How does the SonoPelvicFloor feature simplify assessments?
SonoPelvicFloor automates plane alignment and measurements for pelvic floor assessments, reducing keystrokes by up to 76%.
What is the aim of the Fibroid Mapping feature?
Fibroid Mapping uses AI to standardize and streamline fibroid documentation by mapping, measuring, and classifying fibroids.
How does the fetalHS feature help in fetal heart assessments?
fetalHS provides step-by-step, AI-driven guidance to help identify normal fetal heart anatomy, simplifying and speeding up fetal heart assessments by up to 48%.
ge healthcare (nyse: ge) provides transformational medical technologies and services to meet the demand for increased access, enhanced quality and more affordable healthcare around the world. while we encourage and welcome comments to our linkedin page, these posts from members of the public do not necessarily represent ge healthcare views, and we do not confirm their accuracy or endorse them. ge healthcare is part of highly regulated medical device and pharmaceutical industry. posts and conversations may be removed as a result, but may be forwarded to other people within ge healthcare for follow-up as appropriate. as part of our commitment to you and to the rest of the linkedin members, we will do our best to ensure that the content on the page remains positive. however, since we cannot monitor every post or conversation feed, we realize that the occasional objectionable posts will pop up just from time to time. therefore, the company reserves the right to remove any postings at i
